Porphyromonas gingivalis suppresses adaptive immunity in periodontitis, atherosclerosis, and Alzheimer’s disease

References

• Seymour GJ, Ford PJ, Cullinan MP, Leishman S, Yamazaki K. Relationship between periodontal infections and systemic disease. Clin Microbiol. 2007; 13(Suppl 4): 3–10.
   Google Scholar
• Hajishengallis G, Darveau RP, Curtis MA. The keystone pathogen hypothesis. Nat Rev Microbiol. 2012; 10: 717–25. doi: http://dx.doi.org/10.1038/nrmicro2873.
   Google Scholar
• How KY, Song KP, Chan KG. Porphyromonas gingivalis: an overview of periodontopathic pathogen below the gum line. Front Microbiol. 2016; 7: 53. doi: http://dx.doi.org/10.3389/fmicb.2016.00053.
   Google Scholar
• Hajishengallis G. Immune evasion strategies of Porphyromonas gingivalis. J Oral Biosci. 2011; 53: 233–40. doi: http://dx.doi.org/10.2330/joralbiosci.53.233.
   Google Scholar
• Olsen I, Yilmaz Ö.Modulation of inflammasome activity by Porphyromonas gingivalis in periodontitis and associated systemic diseases. J Oral Microbiol. 2016; 8: 30385. doi: http://dx.doi.org/10.3402/jom.v8.30385.
   Google Scholar
• Olsen I, Singhrao SK. Inflammasome involvement in Alzheimer’s disease. J Alzheimers Dis. 2016; 54: 45–53.
   Web of Science ®Google Scholar
• Olsen I, Hajishengallis G. Major neutrophil functions subverted by Porphyromonas gingivalis. J Oral Microbiol. 2016; 8: 30936. doi: http://dx.doi.org/10.3402/jom.v8.30936.
   Google Scholar
• Olsen I, Singhrao SK. Can oral infection be a risk factor for Alzheimer’s disease?. J Oral Microbiol. 2015; 7: 29143. doi: http://dx.doi.org/10.3402/jom.v7.29143.
   Google Scholar
• Vernal R, Diaz-Guerra E, Silva A, Sanz M, Garcia-Santz JA. Distinct human T-lymphocyte responses triggered by Porphyromonas gingivalis capsular serotypes. J Clin Periodontol. 2014; 41: 19–30. doi: http://dx.doi.org/10.1111/jcpe.12176.
   Google Scholar
• Darveau RP, Hajishengallis G, Curtis MA. Porphyromonas gingivalis as a potential community activist for disease. J Dent Res. 2012; 91: 816–20.
   PubMed Web of Science ®Google Scholar
• Hajishengallis G. Editorial: a toll gate to escape T cells. J Leukoc Biol. 2013; 93: 3–5. doi: http://dx.doi.org/10.1189/jlb.0912465.
   Google Scholar
• Coats SR, Jones JW, Braham PH, Do CT, Braham PH, Bainbridge BW, etal. Human toll-like receptor 4 responses to P. gingivalis are regulated by lipid A 1- and 4’-phosphatase activities. Cell Microbiol. 2009; 11: 1587–99. doi: http://dx.doi.org/10.1111/j.1462-5822.2009.01349.x.
   Google Scholar
• Singhrao SK, Harding A, Poole S, Kesavalu L, Crean S. Porphyromonas gingivalis periodontal infection and its putative links with Alzheimer’s disease. Mediators Inflamm. 2015; 2015: 137357. doi: http://dx.doi.org/10.1155/2015/137357.
   Google Scholar
• Teng YT. Protective and destructive immunity in the periodonticum. Part 2 – T-cell mediated immunity in the periodontium. J Dent Res. 2006; 85: 209–19.
   Web of Science ®Google Scholar
• Kawai T, Matsuyama T, Hosokawa Y, Makihira S, Seki M, Karimbux NY, etal. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am J Pathol. 2006; 169: 987–98.
   PubMed Web of Science ®Google Scholar
• Takeichi D, Haber J, Kawai T, Smith DJ, Moro I, Taubman MA. Cytokine profiles of T-lymphocytes from gingival tissues with pathological pocketing. J Dent Res. 2000; 79: 1548–55.
   PubMed Web of Science ®Google Scholar
• Vernal R, Dutzan N, Chaparro A, Puente J, Valenzuela MA, Gamonal J. Levels of interleukin-17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis. J Clin Periodontol. 2005; 32: 383–9. doi: http://dx.doi.org/10.1111/j.1600-051X.2005.00684.x.
   Google Scholar
• Gemmell E, Yamazaki K, Seymour GJ. The role of T cells in periodontal disease: homeostasis and autoimmunity. Periodontol 2000. 2007; 43: 14–40.
   Web of Science ®Google Scholar
• Gaffen SL, Hajishengallis G. A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. J Dent Res. 2008; 87: 817–28.
   PubMed Web of Science ®Google Scholar
• Graves DT, Oates T, Garlet GP. Review of osteoimmunology and the host response in endodontic and periodontal lesions. J Oral Microbiol. 2011; 3: 5304. doi: http://dx.doi.org/10.3402/jom.v3i0.5304.
   Google Scholar
• Baker PJ, Dixon M, Evans RT, Dufour L, Johnson E, Roopenian DC. CD+ T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice. Infect Immun. 1999; 67: 2804–9.
   PubMed Web of Science ®Google Scholar
• Baker PJ, Dixon M, Roopenian DC. Genetic control of susceptibility to Porphyromonas gingivalis-induced alveolar bone loss in mice. Infect Immun. 2000; 68: 5864–8.
   PubMed Web of Science ®Google Scholar
• Kong YY, Boyle WJ, Penninger JM. Osteoprotegerin ligand: a common link between osteoclastogenesis, lymph node formation and lymphocyte development. Immunol Cell Biol. 1999; 77: 188–93.
   PubMed Web of Science ®Google Scholar
• Theill LE, Boyle WJ, Penninger JM. RANKL-L and RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol. 2002; 20: 795–823.
   PubMed Web of Science ®Google Scholar
• Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, etal. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature. 1999; 402: 304–9.
   PubMed Web of Science ®Google Scholar
• Teng YT, Nguyen H, Gao X, Kong YY, Gorczynski RM, Singh B, etal. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest. 2000; 106: R59–67.
   PubMed Web of Science ®Google Scholar
• Taubman MA, Kawai T. Involvement of T lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Crit Rev Oral Biol Med. 2001; 12: 125–35.
   PubMedGoogle Scholar
• Kawai T, Eisen-Lev R, Seki M, Eastcott JW, Wilson ME, Taubman MA. Requirement of B7 costimulation for Th1-mediated inflammatory bone resorption in experimental periodontal disease. J Immunol. 2000; 164: 2102–9.
   PubMed Web of Science ®Google Scholar
• Valverde P, Kawai T, Taubman MA. Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease. J Bone Min Res. 2004; 19: 155–64.
   PubMed Web of Science ®Google Scholar
• Han X, Kawai T, Eastcott JW, Taubman MA. Bacterial-responsive B lymphocytes induce periodontal bone resorption. J Immunol. 2006; 176: 625–31.
   PubMed Web of Science ®Google Scholar
• Taubman MA, Ebersole JL, Smith DJ. Genco RJ, Mergenhangen SE. Association between systemic and local antibody and periodontal diseases. Host parasite interactions in periodontal diseases. 1982; Washington, DC: American Society for Microbiology. 283–98.
   Google Scholar
• Yoshie H, Taubman MA, Olson CL, Ebersole JL, Smith DJ. Periodontal bone loss and immune characteristics after adoptive transfer of Actinobacillus-sensitized T cells to rats. J Periodontal Res. 1987; 22: 499–505.
   Web of Science ®Google Scholar
• Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev. 1999; 20: 345–57.
   PubMed Web of Science ®Google Scholar
• Valverde P, Kawai T, Taubman MA. Potasium channel-blockers as therapeutic agents to interfere with bone resorption of periodontal disease. J Dent Res. 2005; 84: 488–99.
   PubMed Web of Science ®Google Scholar
• Anderson KM, Olson KE, Estes KA, Flanagan K, Gendelman HE, Mosley RL. Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders. Transl Neurodegener. 2014; 3: 25. doi: http://dx.doi.org/10.1186/2047-9158-3-25.
   Google Scholar
• Moutsopoulos NM, Kling HM, Angelov N, Jin W, Palmer RJ, Nares S, etal. P. gingivalis promotes Th17 inducing pathways in chronic periodontitis. J Autoimmun. 2012; 39: 294–303. doi: http://dx.doi.org/10.1016/j.jaut.2012.03.003.
   Google Scholar
• Gaddis DE, Maynard CL, Weaver CT, Michalek SM, Katz J. Role of TLR2-dependent IL-10 production in the inhibition of the initial IFN-γ T cell response to Porphyromonas gingivalis. J Leukoc Biol. 2013; 93: 21–31. doi: http://dx.doi.org/10.1189/jlb.0512220.
   Google Scholar
• Khalaf H, Bengtsson T. Altered T-cell responses by the periodontal pathogen Porphyromonas gingivalis. PLoS One. 2012; 7: e45192. doi: http://dx.doi.org/10.1371/journal.pone.0045192.
   Google Scholar
• Zheng SG, Wang J, Wang P, Gray JD, Horwitz DA. IL-2 is essential for TGF-beta to convert naïve CD4+CD25- cells to CD25+ Fox3+ regulatory T cells and for expansion of these cells. J Immunol. 2007; 178: 2018–27.
   PubMed Web of Science ®Google Scholar
• Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001; 19: 683–765.
   PubMed Web of Science ®Google Scholar
• Filippi CM, von Herrath MG. IL-10 and the resolution of infections. J Pathol. 2008; 214: 224–30.
   Web of Science ®Google Scholar
• Al-Rasheed A, Scheerens H, Rennick DM, Fletcher HM, Tatakis DN. Accelerated alveolar bone loss in mice lacking interleukin-10. J Dent Res. 2003; 82: 632–5.
   PubMed Web of Science ®Google Scholar
• Sasaki H, Okamatsu Y, Kawai T, Kent R, Taubman M, Stashenko P. The interleukin-10 knockout mouse is highly susceptible to Porphyromonas gingivalis-induced alveolar bone loss. J Periodontal Res. 2004; 39: 432–41.
   PubMed Web of Science ®Google Scholar
• Herminajeng E, Sosroseno W, Bird PS, Seymour GJ. The effects of interleukin-10 depletion in vivo on the immune response to Porphyromonas gingivalis in a murine model. J Periodontol. 2001; 72: 1527–34.
   PubMed Web of Science ®Google Scholar
• Kobayashi R, Kono T, Bolerjack BA, Fukuyama Y, Gilbert RS, Fujihashi M, etal. Induction of IL-10-producing CD4+ T-cells in chronic periodontitis. J Dent Res. 2011; 90: 653–8. doi: http://dx.doi.org/10.1177/0022034510397838.
   Google Scholar
• Kitamura Y, Matono S, Aida Y, Hirofuji T, Maeda K. Gingipains in the culture supernatant of Porphyromonas gingivalis cleave CD4 and CD8 on human T cells. J Periodontal Res. 2002; 37: 464–8.
   Web of Science ®Google Scholar
• Gemmell E, Drysdale KE, Seymour GJ. Gene expression in splenic CD4 and CD8 cells from BALB/c mice immunized with Porphyromonas gingivalis. J Periodontol. 2006; 77: 622–33. doi: http://dx.doi.org/10.1902/jop.2006.050211.
   Google Scholar
• Wang L, Guan N, Jin Y, Lin X, Gao H. Subcutaneous vaccination with Porphyromonas gingivalis ameliorates periodontitis by modulating Th17/Treg imbalance in a murine model. Int Immunopharmacol. 2015; 25: 65–73. doi: http://dx.doi.org/10.1016/j.intimp.2015.01.007.
   Google Scholar
• Wang L, Wang J, Jin Y, Gao H, Lin X. Oral administration of all-trans retinoic acid suppresses experimental periodontitis by modulating the Th17/Treg imbalance. J Periodontol. 2014; 85: 740–50. doi: http://dx.doi.org/10.1902/jop.2013.130132.
   Google Scholar
• Jauregui CE, Wang Q, Wright CJ, Takeuchi H, Uriarte SM, Lamont RJ. Suppression of T-cell chemokines by Porphyromonas gingivalis. Infect Immun. 2013; 81: 2288–95. doi: http://dx.doi.org/10.1128/IAI.00264-13.
   Google Scholar
• Darveau RP, Belton CM, Reife RA, Lamont RJ. Local chemokine paralysis, a novel pathogenic mechanism for Porphyromonas gingivalis . Infect Immun. 1998; 66: 1660–5.
   PubMed Web of Science ®Google Scholar
• Cole AM, Ganz T, Liese AM, Burdick MD, Liu L, Strieter RM. Cutting edge: IFN-inducible ELR- CXC chemokines display defensin-like antimicrobial activity. J Immunol. 2001; 167: 623–7.
   PubMed Web of Science ®Google Scholar
• Yang D, Chen Q, Hoover DM, Staley P, Tucker KD, Lubkowski J, etal. Many chemokines including CCL20/MIP-3α display antimicrobial activity. J Leukoc Biol. 2003; 74: 448–55. doi: http://dx.doi.org/10.1189/jlb.0103024.
   Google Scholar
• Marchesan JT, Morelli T, Lundy SK, Jiao Y, Lim S, Inohara N, etal. Divergence of the systemic immune response following oral infection with distinct strains of Porphyromonas gingivalis. Mol Oral Microbiol. 2012; 27: 483–95. doi: http://dx.doi.org/10.1111/omi.12001.
   Google Scholar
• Waller T, Kesper L, Hirschfeld J, Dommisch H, Kölpin J, Oldenburg J, etal. Porphyromonas gingivalis outer membrane vesicles induce selective TNF tolerance in a TLR4- and mTOR-dependent manner. Infect Immun. 2016; 84: 1194–204. doi: http://dx.doi.org/10.1128/IAI.01390-15.
   Google Scholar
• Mattila KJ, Valle MJ, Nieminen MS, Valtonen VV, Hietaniemi KL. Dental infections and coronary atherosclerosis. Atherosclerosis. 1993; 103: 205–11.
   PubMed Web of Science ®Google Scholar
• Matilla K, Valtonen NM, Rasi V, Huttunen J. Association between dental health and acute myocardial infection. BMJ. 1989; 298: 779–82.
   Google Scholar
• Lockhart PB, Bolger AF, Papapanou PN, Osinbowale O, Trevisan M, Levison ME, etal. Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association. Circulation. 2012; 125: 2520–44.
   PubMed Web of Science ®Google Scholar
• Tonetti MS. Periodontitis and risk for atherosclerosis: an update on intervention trials. J Clin Periodontol. 2009; 36(Suppl 10): 15–19. doi: http://dx.doi.org/10.1111/j.1600-051X.2009.01417.x.
   Google Scholar
• Miyauchi S, Maekawa T, Aoki Y, Miyazawa H, Tabeta K, Nakajima T, etal. Oral infection with Porphyromonas gingivalis and systemic cytokine profile in C57BL/6.KOR-ApoEshl mice. J Periodontal Res. 2012; 47: 402–8. doi: http://dx.doi.org/10.1111/j.1600-0765.2011.01441.x.
   Google Scholar
• Maekawa T, Takahashi N, Tabeta K, Aoki Y, Miyashita H, Miyauchi S, etal. Chronic oral infection with Porphyromonas gingivalis accelerates atheroma formation by shifting the lipid profile. PLoS One. 2011; 6: e20240. doi: http://dx.doi.org/10.1371/journal.pone.0020240.
   Google Scholar
• Pussinen PJ, Alfthan G, Jousilathi P, Paju S, Tuomilehto J. Systemic exposure to Porphyromonas gingivalis predicts incident stroke. Atherosclerosis. 2007; 193: 222–8. doi: http://dx.doi.org/10.1016/j.atherosclerosis.2006.06.027.
   Google Scholar
• Olsen I, Progulske-Fox A. Invasion of Porphyromonas gingivalis strains into vascular cells and tissue. J Oral Microbiol. 2015; 7: 28788. doi: http://dx.doi.org/10.3402/jom.v7.28788.
   Google Scholar
• Cai Y, Kobayashi R, Hashizume-Takizawa T, Kurita-Ochiai T. Porphyromonas gingivalis infection enhances Th17 responses for development of atherosclerosis. Arch Oral Biol. 2014; 59: 1183–91. doi: http://dx.doi.org/10.1016/j.archoralbio.2014.07.012.
   Google Scholar
• Yang J, Wu J, Liu Y, Huang J, Lu Z, Xie L, etal. Porphyromonas gingivalis infection reduces regulatory T cells in infected atherosclerotic patients. PLoS One. 2014; 9: e86599. doi: http://dx.doi.org/10.1371/journal.pone.0086599.
   Google Scholar
• Yuan XL, Chen L, Zhang TT, Ma YH, Zhou YL, Zhao Y, etal. Gastric cancer cells induce human CD4+Foxp3+ regulatory T cells through the production of TGF-β1. World J Gastroenterol. 2011; 17: 2019–27. doi: http://dx.doi.org/10.3748/wjg.v17.i15.2019.
   Google Scholar
• Groux H, O’Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, etal. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 1997; 389: 737–42.
   PubMed Web of Science ®Google Scholar
• Cheng X, Yu X, Ding YJ, Fu QQ, Xie JJ, Tang TT, etal. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol. 2008; 127: 89–97. doi: http://dx.doi.org/10.1016/j.clim.2008.01.009.
   Google Scholar
• Montagne A, Pa J, Zlokovic BV. Vascular plasticity and cognition during normal aging and dementia. JAMA Neurol. 2015; 72: 495–6. doi: http://dx.doi.org/10.1001/jamaneurol.2014.4636.
   Google Scholar
• Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, etal. Alzheimer genetic analysis group. TREM2 variants in Alzheimer’s disease. N Engl J Med. 2013; 368: 117–27. doi: http://dx.doi.org/10.1056/NEJMoa1211851.
   Google Scholar
• Baruch K, Rosenzweig N, Kertser A, Deczkowska A, Sharif AM, Spinrad A, etal. Breaking immune tolerance by targeting Foxp3+ regulatory T cells mitigates Alzheimer’s disease pathology. Nat Commun. 2015; 6: 7967. doi: http://dx.doi.org/10.1038/ncomms8967.
   Google Scholar
• Zenaro E, Pietronigro E, Della Bianca V, Piacentino G, Marongiu L, Budui S, etal. Neutrophils promote Alzheimer’s disease-like pathology and cognitive decline via LFA-1 integrin. Nat Med. 2015; 21: 880–6. doi: http://dx.doi.org/10.1038/nm.3913.
   Google Scholar
• Marsh SE, Abud EM, Lakatos A, Karimzadeh A, Yeung ST, Davtyan H, etal. The adaptive immune system restrains Alzheimer’s disease pathogenesis by modulating microglial function. Proc Natl Acad Sci USA. 2016; 113: E1316–25. doi: http://dx.doi.org/10.1073/pnas.1525466113/-/DC Supplemental.
   Google Scholar
• Singhrao SK, Harding A, Chukkapalli S, Olsen I, Kesavalu L, Crean S. Apolipoprotein E related co-morbidities and Alzheimer’s disease. J Alzheimers Dis. 2016; 51: 935–48. doi: http://dx.doi.org/10.3233/JAD150690.
   Google Scholar
• Togo T, Akiyama H, Iseki E, Kondo H, Ikeda K, Kato M, etal. Occurrence of T cells in the brain of Alzheimer’s disease and other neurological diseases. J Neuroimmunol. 2002; 124: 83–92.
   PubMed Web of Science ®Google Scholar
• Poole S, Singhrao SK, Kesavalu L, Curtis MA, Crean S. Determining the presence of virulence factors in short-term postmortem Alzheimer’s disease brain tissue. J Alzheimers Dis. 2013; 36: 665–77. doi: http://dx.doi.org/10.3233/JAD-121918.
   Google Scholar
• Baron R, Nemirovsky A, Harpaz I, Cohen H, Owens T, Monsonego A. IFN-γ enhances neurogenesis in wild-type mice and in a mouse model of Alzheimer’s disease. FASEB J. 2008; 22: 2843–52. doi: http://dx.doi.org/10.1096/fj.08-105866.
   Google Scholar
• Hohlfeld R. Neurotrophic cross-talk between the nervous and immune systems: relevance for repair strategies in multiple sclerosis?. J Neurol Sci. 2008; 265: 93–6. doi: http://dx.doi.org/10.1016/j.jns.2007.03.012.
   Google Scholar
• Kim JM, Rasmussen JP, Rudensky AY. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol. 2007; 8: 191–7.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. 2008; 133: 775–87.
   PubMed Web of Science ®Google Scholar
• Grubeck-Loebenstein B, Wick G. The aging of the immune system. Adv Immunol. 2002; 80: 243–84.
   PubMed Web of Science ®Google Scholar
• Plackett TP, Boehmer ED, Faunce DE, Kovacs EJ. Aging and innate immune cells. J Leukoc Biol. 2004; 76: 291–9. doi: http://dx.doi.org/10.1189/jlb.1103592.
   Google Scholar
• Sun Y, Li H, Yang M-F, Shu W, Sun M-J, Xu Y. Effects of aging on endotoxin tolerance induced by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli. PLoS One. 2012; 7: 139224. doi: http://dx.doi.org/10.1371/journal.pone.0039224.
   Google Scholar
• Zaric S, Shelburne C, Darveau R, Quinn DJ, Weldon S, Taggart CC, etal. Impaired immune tolerance to Porphyromonas gingivalis lipopolysaccharide promotes neutrophil migration and decreased apoptosis. Infect Immun. 2010; 78: 4151–6. doi: http://dx.doi.org/10.1128/IAI.00600-10.
   Google Scholar
• Kajiya M, Giro G, Taubman MA, Han X, Mayer MP, Kawai T. Role of periodontal pathogenic bacteria in RANKL-mediated bone destruction in periodontal disease. J Oral Microbiol. 2010; 2: 5532. doi: http://dx.doi.org/10.3402/jom.v2i0.5532.
   Google Scholar
• Han X, Kawai T, Taubman MA. Interference with immune-cell-mediated bone resorption in periodontal disease. Periodontol 2000. 2007; 45: 76–94.
   PubMed Web of Science ®Google Scholar
• Taubman MA, Kawai T, Han X. The new concept of periodontal disease pathogenesis requires new and novel therapeutic strategies. J Clin Periodontol. 2007; 34: 367–9.
   PubMed Web of Science ®Google Scholar
• Han X, Lin X, Yu X, Lin J, Kawai T, LaRosa KB, etal. Porphyromonas gingivalis infection-associated periodontal bone resorption is dependent on receptor activator of NF-κB ligand. Infect Immun. 2013; 81: 1502–9.
   Web of Science ®Google Scholar
• Lin X, Han X, Kawai T, Taubman MA. Antibody to receptor activator of NF-κB ligand ameliorates T cell-mediated periodontal bone resorption. Infect Immun. 2011; 79: 911–17.
   PubMed Web of Science ®Google Scholar
• Gaffen SL, Herzberg MC, Taubman MA, Van Dyke TE. Recent advances in host defense mechanisms/therapies against oral infectious diseases and consequences for systemic disease. Adv Dent Res. 2014; 26: 30–7. doi: http://dx.doi.org/10.1177/0022034514525778.
   Google Scholar